Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel
M-14789-41
Approved small_molecule active
Quick answer
Klisyri 10 mg/g ointment, Solaraze 30 mg/g Gel for Actinic Keratosis is a Approved program (small_molecule) at Almirall with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Almirall
- Indication
- Actinic Keratosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active